张予阳 - 沈阳药科大学 - 生命科学与生物制药学院

个人简介

张予阳，女，博士，教授。1984年毕业于沈阳药科大学，获理学学士学位，1990年于同校获中药药理学硕士学位，2003年于同校获药理学博士学位。2009-2010年美国南佛罗里达大学、医学院脑修复研究中心，访问学者。辽宁省药学会药理专业委员会委员，辽宁省细胞生物学学会中药化学专业委员会理事，辽宁省医疗机构制剂审评专家，沈阳市科技计划评估与咨询专家，辽宁科技专家库专家，国家自然科学基金委员会的评议专家，教育部学位中心评审专家，辽宁省科学技术奖励评审专家。作为课题负责人主持了辽宁省教育厅项目2项，作为项目骨干成员承担“重大新药创制”科技重大专项立项课题1项、国家自然科学基金面上项目2项。发表SCI论文20余篇。

研究领域

研究方向一：脑血管药理（药理学）研究方向二：合理用药与药物评价（临床药学）

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1.LanZHANG,LinglongYANG,XiaofeiZHANG,JiaqiLI,LinlinFAN,MoritzBeck-BROICHSITTER,XiaoZHANG,UweMUENSTER,XiuhuaWANG,JingZHAO,YuyangZHANG*,ShiruiMAO*.Sustainedtherapeuticefficacyofbudesonide-loadedchitosanswellablemicroparticlesafterlungdelivery:influenceofinvitrorelease,treatmentintervalanddose.JControlRelease2018,283:163-174(IF=7.877) 2.QianLi,LinglongYang,LinlinFan,ChenLiang,QiujvWang,HuiminWen,JinweiDai,XinLi,YuyangZhang*.ActivityofBruceaJavanicaOilEmulsionagainstGastricUlcersinRodents.AsianJPharmSci2018,13(3):279-88(IF=4.560) 3.KeMa,YaliLu,ShanshanJiang,JiangongTang,XinLi,YuyangZhang*.Therelativeriskandincidenceofimmunecheckpointinhibitorsrelatedpneumonitisinpatientswithadvancedcancer:ameta-analysis.FrontPharmacol2018,9:1430(IF=3.831) 4.GangXing,LiPan,CeYi,XiaoranLi,XinyueGe,YingZhao,YichuangLiu,JinyanLi,AnthonyWoo,BinLin,YuyangZhang*,MaoshengCheng*.Design,synthesisandbiologicalevaluationof5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-onederivativesaspotentβ2-adrenoceptoragonists.BioorganMedChemDOI:10.1016/j.bmc.2018.10.043(IF=2.881) 5.ChaoZhao,AnthonyWoo,XitongYu,YaruGu,XiruiSong,NanAn,YuyangZhang*.MICRODOMAINELEMENTSOFAIRWAYSMOOTHMUSCLEINCAICIUMEGULATIONANDCELLPROLIFERATION.JPhysiolPharmacol2018,69(2)DOI:10.26402/jpp.2018.2.01(IF=2.478) 6.XiaoxueJiang,HuanHe,ZhehuiXie,HuiminWen,XiaoranLi,XinLi,JunMa,KazuoUmezawa,YuyangZhang*.DehydroxymethylepoxyquinomicinSuppressesAtopicDermatitis-likeLesioninaStratumCorneum-RemovedMurineModelthroughNF-κBinhibition.ImmunopharmacolImmunotoxicol2018(IF=2.024) 7.YihanWang,ChaoZhao,QiujvWang,HuiminWen,YaruGu,LinlinFan,ChaoMa,MaoshengCheng,YuyangZhang*.Investigationof(-)-Linarinicacidandoneofitsderivativesagainstcerebralischemiainmice.AsianJPharmSci2017,12(2):165-71(IF=4.560) 8.XiaoxueJiang,YiLan,BingWei,CailingDai,YaruGu,JunMa,XiaoyanLiu,KazuoUmezawa,YuyangZhang*.ExternalApplicationofNF-kBinhibitorDHMEQsuppressesdevelopmentofDNCB/OX-inducedatopicdermatitisinBALB/cmice.ImmunopharmacolImmunotoxicol2017,39(3):157-64(IF=2.024) 9.XiruiSong,YuyangZhang*,HongyunWang,HuiminWen,CaoZhao,YiLan,LiPan,ChiZhang,MaoshengCheng.Stereoselectivityoftradinterol’sinhibitiononproliferationofairwaysmoothmusclecellsinducedbyacetylcholinethroughsuppressingCa²⁺signaling.JPhysiolPharmacol2016,67(3):363-75(IF=2.804) 10.YanxinRen,BingWei,XiruiSong,NanAn,YiyingZhou,XinxinJin,YuyangZhang*.Edaravone’sFreeRadicalScavengingMechanismsofNeuroprotectionagainstCerebralIschemia:ReviewoftheLiterature.IntJNeurosci2015,125(8):555-65(IF=1.528)

学术兼职

1.辽宁省药学会药理专业委员会，委员； 2.辽宁省细胞生物学学会中药化学专业委员会，理事；